benefitscanada.com·há 23 dias Plan sponsors report slowing drug costs, but inflation remains a persistent driver: report
Although overall drug cost growth slowed in 2025, inflation continues to drive cost increases among Canadian benefits plan sponsors, according to a new report by Medavie Blue Cross. It found in 2025,
